These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 3317347

  • 1. Comparative multicentre study of the immunogenicity of different hepatitis B vaccines in healthy volunteers.
    Goudeau A, Denis F, Mounier M, Dubois F, Klein J, Godefroy A, Ballet M, Mountij A.
    Postgrad Med J; 1987; 63 Suppl 2():125-8. PubMed ID: 3317347
    [Abstract] [Full Text] [Related]

  • 2. Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults.
    Just M, Berger R, Just V.
    Postgrad Med J; 1987; 63 Suppl 2():121-3. PubMed ID: 3317346
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity of yeast-derived hepatitis B vaccines in young adults.
    Bergamini F, Zanetti A.
    Postgrad Med J; 1987; 63 Suppl 2():137-8. PubMed ID: 3317349
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of a yeast-derived hepatitis B vaccine (Engerix-B) in healthy young adults.
    Crovari P, Crovari PC, Petrilli RC, Icardi GC, Bonanni P.
    Postgrad Med J; 1987; 63 Suppl 2():161-4. PubMed ID: 3317356
    [Abstract] [Full Text] [Related]

  • 5. Effects of a recombinant yeast-derived hepatitis B vaccine in healthy adults.
    Scheiermann N, Gesemann KM, Kreuzfelder E, Paar D.
    Postgrad Med J; 1987; 63 Suppl 2():115-9. PubMed ID: 3317345
    [Abstract] [Full Text] [Related]

  • 6. Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccine.
    Wiedermann G, Ambrosch F, Kremsner P, Kunz C, Hauser P, Simoen E, André F, Safary A.
    Postgrad Med J; 1987; 63 Suppl 2():109-13. PubMed ID: 3317344
    [Abstract] [Full Text] [Related]

  • 7. Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine.
    André FE, Safary A.
    Postgrad Med J; 1987; 63 Suppl 2():169-77. PubMed ID: 3317357
    [Abstract] [Full Text] [Related]

  • 8. Active immunization against hepatitis B: immunogenicity of a recombinant DNA vaccine in females, heterosexual and homosexual males.
    Laukamm-Josten U, von Laer G, Feldmeier H, Bienzle U, Uy A, Thomssen R, Guggenmoos-Holzmann I.
    Postgrad Med J; 1987; 63 Suppl 2():143-6. PubMed ID: 3317351
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunogenicity of a recombinant hepatitis B vaccine in haemodialysis patients.
    Bruguera M, Cremades M, Mayor A, Sánchez Tapias JM, Rodés J.
    Postgrad Med J; 1987; 63 Suppl 2():155-8. PubMed ID: 3317354
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Yeast-derived hepatitis B vaccine in thalassaemic patients: a preliminary report.
    Giammanco G, De Grandi V, Pignato S, Dolci C, Congia M, Pisu C, De Virgiliis S.
    Postgrad Med J; 1987; 63 Suppl 2():151-4. PubMed ID: 3317353
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of a recombinant DNA hepatitis B vaccine in neonates.
    Meheus A, Alisjahbana A, Vranckx R, Sukadi A, Usman A, Ngantung W, Sugita E, Safary A, André F, Reniers J.
    Postgrad Med J; 1987; 63 Suppl 2():139-41. PubMed ID: 3317350
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A, Kulkarni PS, Bhave S, Bavdekar A, Naik SS, Pandit AN.
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [Abstract] [Full Text] [Related]

  • 18. Immunological properties of recombinant HBsAg produced in yeast.
    Hauser P, Voet P, Simoen E, Thomas HC, Pêtre J, De Wilde M, Stephenne J.
    Postgrad Med J; 1987 Oct; 63 Suppl 2():83-91. PubMed ID: 2446304
    [Abstract] [Full Text] [Related]

  • 19. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R, Smetana J, Sindelár R, Cecetková B, Prymula R, Kohl I.
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.